NYC Hep B Coalition
NYC Hep C Task Force

Connect on LinkedIn

Subscribe to Posts


 

Subscribe to Posts


 

News Archives

WHO Issues its First Hepatitis B Treatment Guidelines

The World Health Organization (WHO) issued its first-ever guidance for the treatment of chronic hepatitis B. Worldwide, some 240 million people have chronic hepatitis B virus with the highest rates of infection in Africa and Asia. People with chronic hepatitis B infection are at increased risk of dying from cirrhosis and liver cancer. Key recommendations include: … Continue reading WHO Issues its First Hepatitis B Treatment Guidelines

NYS DOH approves Viekira Pak as preferred drug for Hep C for FFS Medicaid beneficiaries

At the Feb 26, 2015 NYSDOH Drug Utilization Review Board meeting, the board voted to approve Viekira Pak as its preferred drug for persons chronically infected with HCV and enrolled in FFS Medicaid. Viekira Pak will be available for all chronically infected persons regardless of disease severity. This drug is also FDA approved for HIV … Continue reading NYS DOH approves Viekira Pak as preferred drug for Hep C for FFS Medicaid beneficiaries

Birthing Centers | Download Hep B Vaccine Birth Dose Guide

Hepatitis B: What Hospitals Need to Do to Protect Newborns A comprehensive guide for implementing the hepatitis B vaccine birth dose: The Immunization Action Coalition’s  (IAC) comprehensive guidebook Hepatitis B: What Hospitals Need to Do to Protect Newborns is a complete resource for helping hospitals and birthing centers establish, implement, and optimize their birth dose … Continue reading Birthing Centers | Download Hep B Vaccine Birth Dose Guide

New Data | Hep B Birth Dose Coverage by NYC Facility. NYC Dept of Health, 2015

Hepatitis B Birth Dose Coverage by NYC Facility Percent of infants who received hepatitis B vaccine within 3 days of birth by delivery facility, NYC, 2012. Published by the NYC Health Department, March 2015. Hep Free NYC supports the Immunization Action Coalition’s National Hep B Birth Dose Honor Roll initiative. Learn more about this initiative … Continue reading New Data | Hep B Birth Dose Coverage by NYC Facility. NYC Dept of Health, 2015

Resources | CEI Line- NYS DOH Clinical Education Initiative

CEI Line NYS DOH Clinical Education Initiative connects medical providers to experienced specialists about Hepatitis C as well as HIV, PrEP, PEP, and STDs. After providing general information about your question or case, an experienced clinician will be connected with you to answer your questions and provide guidance. For medical providers only – not for general … Continue reading Resources | CEI Line- NYS DOH Clinical Education Initiative

Webinar | Navigating Hep C: What Patients Need to Know

NVHR Webinar: Navigating Hepatitis C: What Patients Need to Know Please register for our upcoming webinar: Navigating Hepatitis C: What Patients Need to Know. This webinar, which will be held on March 18, 2015, at 2 pm Eastern, will cover the most important elements that patients need to know regarding screening, access to care, receiving … Continue reading Webinar | Navigating Hep C: What Patients Need to Know

Nominations Needed for AASLD/IAS-USA HCV Guidance Panel

Community Representative Nominations for the HCV Guidance Panel Needed The AASLD and IDSA in collaboration with IAS–USA HCV Guidance Panel is seeking an additional community representative to serve on the panel that drafts the Recommendations for Testing, Managing, and Treating Hepatitis C. Community representatives serve a 2 to 3 year term, similar to the scientific … Continue reading Nominations Needed for AASLD/IAS-USA HCV Guidance Panel

Job | Senior Program Analyst, Viral Hepatitis/HIV/STI @ NACCHO

The National Association of County and City Health Officials (NACCHO), a national organization representing approximately 3,000 local health departments (LHDs) nationwide, has an immediate opening for a Senior Program Analyst. Position Summary: A Senior Program Analyst is an individual contributor in a specific area of expertise and is accountable for professional functions and/or systems. Work … Continue reading Job | Senior Program Analyst, Viral Hepatitis/HIV/STI @ NACCHO

#JustB – AAPCHO Launches Hep B Storybank to overcome stigma

OAKLAND, January 26, 2015 – The Association of Asian Pacific Community Health Organizations (AAPCHO), today launched new a website highlighting stories of Asian Americans and Pacific Islanders (AAPIs) impacted by hepatitis B. The #justB website was created to bring more attention to hepatitis B and the impact it has on the Asian American community, as well as … Continue reading #JustB – AAPCHO Launches Hep B Storybank to overcome stigma

Viral Hep Coordinators are Vital. CDC AIDS.gov Blog

Dr. John Ward, Director of the Division of Viral Hepatitis at the Centers for Disease Control and Prevention, authored an article entitled “Viral Hepatitis Prevention Coordinators, a Vital CDC Program Helping to Achieve the Goals of the Viral Hepatitis Action Plan” at blog.AIDS.gov on January 9th. The Viral Hepaitits Prevention Coordinators (VHPCs) program began in … Continue reading Viral Hep Coordinators are Vital. CDC AIDS.gov Blog

Congratulations! Dr. Su Wang – New Board Member @ World Hep Alliance

New Regional Board Members Our Executive Board is vital to the governance of the Alliance and, crucially, to provide representation for our patient groups on a regional level. Following a largely contested election, we are happy to now announce our new Regional Board Members for 2014-2016. Our voting members have spoken and votes have been … Continue reading Congratulations! Dr. Su Wang – New Board Member @ World Hep Alliance

Open for Comment | NYS Medicaid Harvoni Clinical Criteria

Update 12/15/14: The meeting summary is now available. Outcome of the HARVONI clinical criteria review at the New York State Drug Utilization Review Board (DURB) meeting on November 20th, 2014. The NYS DURB has decided that the newly approved HCV medication Harvoni will use the same Medicaid clinical criteria approved for Solvadi in October, 2014. The criteria includes prioritization … Continue reading Open for Comment | NYS Medicaid Harvoni Clinical Criteria

Olysio-Sovaldi Combo Becomes 2nd FDA-approved All-oral HCV Treatment

Olysio has been approved by the FDA, in combination with Sovaldi, for the treatment of Hepatitis C. It is substantially more expensive than Harvoni; although it depends on treatment time, a 12-week Harvoni treatment costs $94,500, compared to the Olysio-Sovaldi 12-week tag of $150,360. Olysio in combination with Sovaldi is the second Hepatitis C combination treatment regimen … Continue reading Olysio-Sovaldi Combo Becomes 2nd FDA-approved All-oral HCV Treatment

AASLD Poster | Check Hep C: A Community Based Approach to HCV Diagnosis in High Risk Populations

AASLD Poster | Check Hep C: A Community Based Approach to HCV Diagnosis in High Risk Populations Check Hep C was implemented in 2012-2013 by the New York City Department of Health and Mental Hygiene (DOHMH) as a year-long demonstration project designed to increase screening, diagnosis, and linkage to care for persons chronically infected with … Continue reading AASLD Poster | Check Hep C: A Community Based Approach to HCV Diagnosis in High Risk Populations

Data Match | TB & Viral Hepatitis, New York City, 2000–2010

 Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000-2010. Epidemiol Infect. 2014 Nov. Bushnell G, Stennis NL, Drobnik AM, Proops DC, Ahuja SD, Bornschlegel K, Fuld J. Abstract SUMMARY Literature surrounding the burden of and factors associated with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in … Continue reading Data Match | TB & Viral Hepatitis, New York City, 2000–2010

Report | Duplicate Hep C Antibody Testing in NYC (NYC Dept of Health)

An evaluation of duplicate Hep C antibody testing conducted by NYC Department of Health staff has been published in the latest issue of Public Health Reports, Volume 129, Number 6, November/December 2014. ABSTRACT Repeating a hepatitis C virus antibody test for a person who previously tested positive provides no new information, wastes resources, and may reflect poor … Continue reading Report | Duplicate Hep C Antibody Testing in NYC (NYC Dept of Health)

Open for Comment | Harvoni Being Presented at NYS DURB Nov. 20 (Albany)

Update 12/15/14: Click here for results of the 11/20/14 NYS DURB meeting. The next NYSDOH Drug Utilization Review (DUR) Board meeting is scheduled for November 20, 2014 in Albany. View info on the meeting on the NYS DOH website. A link to the full meeting agenda can be found here. Harvoni will be presented at this meeting. Public … Continue reading Open for Comment | Harvoni Being Presented at NYS DURB Nov. 20 (Albany)

Liver Cancer Awareness Campaign is Underground! American Liver Foundation

LIVER CANCER CAMPAIGN comes to New York City!The American Liver Foundation (ALF) has announced a special educational campaign commemorating October as Liver Cancer Awareness Month. Sponsored by Bayer and Onyx Pharmaceuticals, the campaign features vibrant, eye catching ads on New York City taxis, subways and buses! The ads urge people at risk for liver cancer to … Continue reading Liver Cancer Awareness Campaign is Underground! American Liver Foundation

Medicare Guidelines | HCV screening for baby boomer & at risk beneficiaries

Overview: CMS has finalized its decision to reimburse for HCV screening in primary care settings, for individuals who are Medicare eligible and either “high risk” or born between 1945-1965. “High risk” is defined as persons with a current or past history of illicit injection drug use; and persons who have a history of receiving a blood transfusion … Continue reading Medicare Guidelines | HCV screening for baby boomer & at risk beneficiaries

Harvoni: FDA Approved – Combo Pill for Hep C Treatment

Today, the FDA approved Harvoni, a fixed-dose combination pill of ledipasvir and sofosbuvir produced by Gilead Sciences, Inc. The following information was released by the FDA along with the approval. The complete product label will be available soon at DailyMed or at Drugs@FDA. Also see: FDA Press Release on the approval, and Harvoni Patient Information     On October … Continue reading Harvoni: FDA Approved – Combo Pill for Hep C Treatment